REZOLUTE, INC. Total Assets
REZOLUTE, INC. (RZLT) had Total Assets of $112.85 million as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-09-24
- 2026-06-30: Assets $112.85M.
- 2026-03-31: Assets $125.46M.
- 2025-12-31: Assets $138.63M.
- 2025-09-30: Assets $158.66M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $112.85M 10-K · filed 2026-09-24 | |
| 2026-03-31 | $125.46M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $138.63M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $158.66M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $175.49M 10-K · filed 2026-09-24 | |
| 2025-03-31 | $94.74M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $112.01M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $123.41M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $132.74M 10-K · filed 2025-09-17 | |
| 2024-03-31 | $87.74M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $102.15M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $113.00M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $123.72M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $134.21M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $150.21M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $155.99M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $152.42M 10-K · filed 2023-09-14 | |
| 2022-03-31 | $69.57M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $83.41M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $38.76M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $42.61M 10-K · filed 2022-09-15 | |
| 2021-03-31 | $32.93M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $38.90M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $7.41M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $10.96M 10-K · filed 2021-09-15 | |
| 2020-03-31 | $14.70M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $20.57M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $26.57M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $12.25M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $15.46M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $455.66K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $1.07M 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $2.50M 10-K · filed 2019-09-10 | $2.50M 10-K · filed 2018-10-15 |
| 2018-03-31 | $5.14M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $6.32M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $9.80M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.63M 10-K · filed 2018-10-15 | |
| 2017-03-31 | $10.80M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $9.94M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $10.06M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $10.90M 10-K · filed 2017-09-22 | |
| 2016-03-31 | $8.79M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.53M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $9.17M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $11.26M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $12.06M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $10.72M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $6.27M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $7.40M 10-K · filed 2015-09-28 | |
| 2014-03-31 | $6.27M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $2.15M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $863.57K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.10M 10-K · filed 2014-09-30 | |
| 2013-03-31 | $1.57M 10-Q · filed 2013-05-15 | |
| 2012-09-30 | $480.00 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $1.07M 10-K · filed 2013-09-11 | $5.13K 10-K/A · filed 2012-11-09 |
| 2012-03-31 | $8.89K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $565.79K 10-K · filed 2013-09-11 | $15.85K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $23.48K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $37.03K 10-K/A · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |